Mirena
MIRENA®
(levonorgestrel-releasing) Intrauterine System
PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES
DRUG DESCRIPTION
MIRENA® (levonorgestrel-releasing intrauterine system) consists of a T-shaped polyethylene frame (T-body) with a steroid reservoir (hormone elastomer core) around the vertical stem. The reservoir consists of a cylinder, made of a mixture of levonorgestrel and silicone (polydimethylsiloxane), containing a total of 52 mg levonorgestrel. The reservoir is covered by a silicone (polydimethylsiloxane) membrane. The T-body is 32 mm in both the horizontal and vertical directions. The polyethylene of the T-body is compounded with barium sulfate, which makes it radiopaque. A monofilament brown polyethylene removal thread is attached to a loop at the end of the vertical stem of the T-body.
Schematic drawing of MIRENA
![]() |
INSERTER
MIRENA is packaged sterile within an inserter. The inserter, which is used for insertion of MIRENA into the uterine cavity, consists of a symmetric two-sided body and slider that are integrated with flange, lock, pre-bent insertion tube and plunger. Once MIRENA is in place, the inserter is discarded.
DIAGRAM OF INSERTER
![]() |
MIRENA is intended to provide an initial release rate of 20 µg/day of levonorgestrel.
Levonorgestrel USP, (-)-13-Ethyl-17-hydroxy-18,19-dinor-17α- pregn-4-en-20-yn-3-one, the active ingredient in MIRENA, has a molecular weight of 312.4, a molecular formula of C21H28O2, and the following structural formula:
![]() |
Generic Name: Levonorgestrel-Releasing Intrauterine System
Women's Health
Find out what women really need.
Teens and STDs
Your kids are learning about AIDS and HIV in school, but what about other STDs?See more WebMD Videos »



